Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Chiesi Limited, 333 Styal Road, Manchester, M22 5LG, United Kingdom
Clipper 5 mg gastro-resistant prolonged-release tablets.
| Pharmaceutical Form |
|---|
|
Gastro-resistant prolonged-release tablets. Each ivory white, coated tablet is round and convex. |
Each tablet contains 5 mg of beclometasone dipropionate.
Excipient with known effect: lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Beclometasone |
Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity. |
| List of Excipients |
|---|
|
In Tablet Core: Lactose monohydrate In Tablet Coat: Macrogol 4000 |
PVC/PVDC/Al/PVDC blister.
Packs of 10 or 30 tablets.
Not all pack sizes may be marketed.
Chiesi Limited, 333 Styal Road, Manchester, M22 5LG, United Kingdom
PL 08829/0153
7th January 2005
| Drug | Countries | |
|---|---|---|
| CLIPPER | Spain, Italy, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
